quizartinib dihydrochloride

Spain

Drugs containing this active substance

  • VANFLYTA 17.7 MG FILM-COATED TABLETS

    It is used in combination with chemotherapy to treat adults with acute myeloid leukemia (AML) who have a specific mutation called FLT3-ITD. It may also be used after a bone marrow transplant once the patient has recovered sufficiently.

    Form: tablets, film-coated

    Active substance Dosage
    quizartinib dihydrochloride 17,7 mg

    ATC: L01E L01EX L01EX11

    Manufacturer: Daiichi Sankyo Europe Gmbh

  • VANFLYTA 26.5 MG FILM-COATED TABLETS

    It is used in combination with chemotherapy to treat adults with acute myeloid leukemia (AML) who have a specific mutation called FLT3-ITD. It may also be used after a bone marrow transplant once the patient has recovered sufficiently.

    Form: tablets, film-coated

    Active substance Dosage
    quizartinib dihydrochloride 26,5 mg

    ATC: L01E L01EX L01EX11

    Manufacturer: Daiichi Sankyo Europe Gmbh